Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
WALTER V KLEMP Insider Profile
4 Followers
WALTER V KLEMP, EC, Director at Soliton, holds 57.03K shares in Moleculin Biotech (Ticker: MBRX), holds 0.00 shares in Soliton (Ticker: SOLY), holds ― shares in Autonomix Medical, Inc. (Ticker: AMIX).
Profitable Transactions
0 out of 4 Profitable Transactions
Average Return
-57.60%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that WALTER V KLEMP holds in companies
Most Profitable Insider Trade
The most profitable trade made by WALTER V KLEMP
WALTER V KLEMP's Trading History
Soliton
Dec 17, 2021
―
Uninformative Sell
9.61M
$0.00
Moleculin Biotech
Jul 05, 2024
CEO & President, Director
Uninformative Buy
2.65K
$151.14K
Autonomix Medical, Inc.
―
Director
―
―
List of latest transactions for each holding click on a transaction to see WALTER V KLEMP's performance on stock
You May Also Like
WALTER V KLEMP insider profile FAQ
What is the percentage of profitable transactions made by WALTER V KLEMP?
The percentage of profitable transactions made by WALTER V KLEMP is 0%.
What is the average return per transaction made by WALTER V KLEMP?
The average return per transaction made by WALTER V KLEMP is -57.60%.
What stocks does WALTER V KLEMP hold?
WALTER V KLEMP holds: SOLY, MBRX, AMIX stocks.
What was WALTER V KLEMP’s latest transaction?
WALTER V KLEMP latest transaction was an Uninformative Buy of $2.65K.
What was WALTER V KLEMP's most profitable transaction?
WALTER V KLEMP’s most profitable transaction was an Informative Buy of MBRX stock on November 18, 2022. The return on the trade was -43.80%.
What is WALTER V KLEMP's role in Soliton?
WALTER V KLEMP's role in Soliton is EC, Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.